# Adlai Nortye Group Ltd. (ANL)

> Source: Nexqual · https://nexqual.com/ANL · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Adlai Nortye Group Ltd. (ANL), nexqual.com/ANL" · informational, not investment advice.

**Price:** USD 12.09 (+11.12% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 10.88 · day 11.23–12.46 · 52w 0.88–17.25 · market cap $779M · NGM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (7 analysts), mean target USD 29.5 (range 20–49).
- Total return with dividends: 1Y +650.9% vs S&P 500 +18.1%; 5Y -19.4% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 7 analysts; mean target USD 29.5 (low 20, high 49).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-10 | Jefferies | Initiated | Buy | $31 |
| 2026-09-08 | HC Wainwright & Co. | Reiterated | Buy | $20 |
| 2026-06-22 | Cantor Fitzgerald | Initiated | Overweight |  |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2023-09-25) |
|---|---|---|
| Total return | +650.9% | -19.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +656.1% | -6.8% |
| Volatility (annualized) | 133.8% | 126.2% |
| Max drawdown | -47.0% (Oct 2025→Dec 2025) | -93.3% (Sep 2023→Dec 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/ANL · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt